MARC E. GOLDBERG

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENANTA PHARMACEUTICALS INC

Filing Date Source Excerpt
2014-01-10 Consists of 554,467 shares beneficially owned by BioVentures Investors Limited Partnership II, for which Mr. Goldberg may be deemed to share voting and investment control.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22